GONZALEZ CANETE, Natalia    DURAN AGUERO, Samuel. Soya isoflavones and evidences on cardiovascular protection. []. , 29, 6, pp.1271-1282. ISSN 1699-5198.  https://dx.doi.org/10.3305/nh.2014.29.6.7047.

Soya isoflavones represent a group of non-nutritive, bioactive compounds, of non-steroidal phenolic nature that are present in soy bean and derived foods. They share with other compounds the capacity of binding to estrogenic receptors from different cells and tissues so that they may act as phytoestrogens. The current interest in these compounds comes from the knowledge that in Asian populations with high levels of their consumption the prevalence of cancer and cardiovascular disease is lower, as compared to the Western countries populations. This cardiovascular benefit would be the result not only of the modulation of plasma lipids, which is a widely studied mechanism. This paper reviews the published evidence about the beneficial effects of soya isoflavones and the different mechanisms of action that would benefit cardiovascular health and that surpass the mechanisms traditionally approached such as the modulation of plasma lipids, and that implicate the regulation of cellular and enzymatic functions in situations such as inflammation, thrombosis, and atherosclerotic progression.

: Soya isoflavones; Cardiovascular disease; Phytoestrogens.

        · |     · |     · ( pdf )